These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25550184)

  • 1. Decorin in human oral cancer: a promising predictive biomarker of S-1 neoadjuvant chemosensitivity.
    Kasamatsu A; Uzawa K; Minakawa Y; Ishige S; Kasama H; Endo-Sakamoto Y; Ogawara K; Shiiba M; Takiguchi Y; Tanzawa H
    Biochem Biophys Res Commun; 2015 Jan; 457(1):71-6. PubMed ID: 25550184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
    Harada K; Ferdous T; Itashiki Y; Takii M; Mano T; Mori Y; Ueyama Y
    Anticancer Res; 2009 Apr; 29(4):1263-70. PubMed ID: 19414373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined effects of the oral fluoropyrimidine anticancer agent, S-1 and radiation on human oral cancer cells.
    Harada K; Kawaguchi S; Supriatno ; Onoue T; Yoshida H; Sato M
    Oral Oncol; 2004 Aug; 40(7):713-9. PubMed ID: 15172641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of schedule-dependent metronomic S-1 chemotherapy in human oral squamous cell carcinoma cells.
    Ferdous T; Harada K; Kin T; Harada T; Ueyama Y
    Int J Oncol; 2013 Jul; 43(1):271-9. PubMed ID: 23695365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S-1 inhibits tumorigenicity and angiogenesis of human oral squamous cell carcinoma cells by suppressing expression of phosphorylated Akt, vascular endothelial growth factor and fibroblast growth factor-2.
    Harada K; Supriatno ; Kawashima Y; Yoshida H; Sato M
    Int J Oncol; 2007 Feb; 30(2):365-74. PubMed ID: 17203218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Predictive value of orotate phosphoribosyltransferase in chemoresistant patients with gastric carcinoma who underwent S-1-based neoadjuvant/adjuvant chemotherapy].
    Sakurai Y; Kamoshida S; Furuta S; Sunagawa R; Inaba K; Isogaki J; Komori Y; Uyama I; Tsutsumi Y
    Gan To Kagaku Ryoho; 2008 Jul; 35(7):1147-55. PubMed ID: 18633253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and toxicity of S-1 plus cisplatin combination neoadjuvant chemotherapy in patients with oral cancer.
    Kawasaki G; Yoshitomi I; Yanamoto S; Yamada S; Mizuno A
    Gan To Kagaku Ryoho; 2011 Jun; 38(6):951-7. PubMed ID: 21677485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Immunological Impact of Chemotherapy on the Tumor Microenvironment of Oral Squamous Cell Carcinoma.
    Takakura H; Domae S; Ono T; Sasaki A
    Acta Med Okayama; 2017 Jun; 71(3):219-226. PubMed ID: 28655941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A quantitative evaluation of the determinant proteins for S-1 responsiveness in a biopsy specimen assists in patient selection to neoadjuvant therapy in cases of advanced gastric cancer.
    Hashiguchi K; Kitajima Y; Kai K; Hiraki M; Nakamura J; Tokunaga O; Noshiro H; Miyazaki K
    Int J Oncol; 2010 Aug; 37(2):257-64. PubMed ID: 20596652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S-1, an oral fluoropyrimidine, enhances radiation response of DLD-1/FU human colon cancer xenografts resistant to 5-FU.
    Nakata E; Fukushima M; Takai Y; Nemoto K; Ogawa Y; Nomiya T; Nakamura Y; Milas L; Yamada S
    Oncol Rep; 2006 Sep; 16(3):465-71. PubMed ID: 16865244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of optimal schedule of concurrent radiotherapy with S-1 for oral squamous cell carcinoma.
    Harada K; Ferdous T; Yoshida H
    Oncol Rep; 2007 Nov; 18(5):1077-83. PubMed ID: 17914556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
    Itashiki Y; Harada K; Ferdous T; Yoshida H
    Anticancer Res; 2007; 27(4B):2365-75. PubMed ID: 17695527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of a novel oral formation of 5-fluorouracil in combination with low-dose cisplatin as preoperative chemotherapy of oral squamous cell carcinoma.
    Nakazawa M; Ohnishi T; Ohmae M; Chisoku H; Yui S; Iwai S; Sumi T; Fukuda Y; Kishino M; Yura Y
    Int J Clin Pharmacol Res; 2005; 25(3):115-22. PubMed ID: 16366419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of oral squamous cell carcinoma responding to S-1].
    Harada K; Tamatani T; Bando T; Yoshida H
    Gan To Kagaku Ryoho; 2007 Sep; 34(9):1455-8. PubMed ID: 17876145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S-1 mediates the inhibition of lymph node metastasis in oral cancer cells.
    Sato H; Hatori M; Ando Y; Kurihara Y; Takayama S; Shirota T; Tachikawa T; Shintani S
    Oncol Rep; 2009 Oct; 22(4):719-24. PubMed ID: 19724848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymidylate synthase expression in oral squamous cell carcinoma predicts response to S-1.
    Harada K; Kawashima Y; Yoshida H; Sato M
    Oncol Rep; 2006 Jun; 15(6):1417-23. PubMed ID: 16685374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical relevance of thymidylate synthase (TS) activity for S-1-based chemotherapy in squamous cell carcinoma of the oral cavity.
    Koga M; Anegawa E; Yoh J; Tsuyama H; Sakaino H; Iwamoto O; Koga C; Kusukawa J
    Br J Oral Maxillofac Surg; 2010 Mar; 48(2):88-93. PubMed ID: 19576666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher Decorin Levels in Bone Marrow Plasma Are Associated with Superior Treatment Response to Novel Agent-Based Induction in Patients with Newly Diagnosed Myeloma - A Retrospective Study.
    Huang SY; Lin HH; Yao M; Tang JL; Wu SJ; Hou HA; Chou WC; Chou SC; Hsu SC; Ko BS; Lu HY; Tsay W; Tien HF
    PLoS One; 2015; 10(9):e0137552. PubMed ID: 26379028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Two cases of advanced gastric cancer completely responding to S-1 neoadjuvant chemotherapy].
    Komatsu H; Morimoto J; Yamashita Y; Ikeya T; Yamazoe S; Kodai S; Shimizu S; Yamamoto A; Kanazawa A; Inoue T; Tsukamoto T; Ikehara T; Nishiguchi Y
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2339-41. PubMed ID: 22202375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical analyses of oral squamous cell carcinoma patients showing a complete response to chemotherapy with S-1 alone].
    Nakamura M; Koga M; Aoki M; Iwamoto O; Koga C; Kusukawa J
    Gan To Kagaku Ryoho; 2011 Nov; 38(11):1841-3. PubMed ID: 22083193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.